Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012

Njau, Joseph; Janta, Denisa; Stanescu, Aurora; Pallas, Sarah S.; Pistol, Adriana; Khetsuriani, Nino; Reef, Susan; Ciurea, Daniel; Butu, Cassandra; Wallace, Aaron S.; Zimmerman, Laura

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012

Published Date:

June 2019

Source:

Emerg Infect Dis. 25(6):1101-1109

Language:

English

[PDF-720.17 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Njau, Joseph ; Janta, Denisa ; Stanescu, Aurora ; Pallas, Sarah S. ; Pistol, Adriana ; ... More ▼

Description:

We estimated the economic impact of concurrent measles and rubella outbreaks in Romania during 2011-2012. We collected costs from surveys of 428 case-patients and caretakers, government records, and health staff interviews. We then estimated financial and opportunity costs. During the study period, 12,427 measles cases and 24,627 rubella cases were recorded; 27 infants had congenital rubella syndrome (CRS). The cost of the outbreaks was US $9.9 million. Cost per case was US $439 for measles, US $132 for rubella, and US $44,051 for CRS. Up to 36% of households needed to borrow money to pay for illness treatment. Approximately 17% of patients continued to work while ill to pay their treatment expenses. Our key study findings were that households incurred a high economic burden compared with their incomes, the health sector bore most costs, and CRS costs were substantial and relevant to include in rubella outbreak cost studies.

Subject:

[+]

Pubmed ID:

31107215

Pubmed Central ID:

PMC6537719

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	18-0339-F.gif	image/gif
	18-0339-F.jpg	image/jpeg
	18-0339-Techapp-s1.pdf	application/pdf
	18-0339.nxml	text/xml

No Related Documents.

You May Also Like:

Report on the Global Immunization Division research program, 2011-2013

Corporate Authors:

Center for Global Health (U.S.). Global Immunization Division.

Published Date:

May 2014

Description:

Beginning in FY 2011, the Vaccine Preventable Disease Eradication and Elimination Branch (VPDEEB), Global Immunization Division (GID), Centers for Disease Control and Prevention (CDC), established a competitive “request for proposal” mechanism to...

File Type:

[PDF - 2.04 MB]
Measles & Rubella Initiative annual report 2012

Corporate Authors:

Measles & Rubella Initiative.. American Red Cross.. Centers for Disease Control and Prevention (U.S.). UNICEF.. United Nations Foundation.. World Health Organization..

Published Date:

2013

Description:

Global progress in the past decade against measles has been stunning. As more countries immunize more children, measles deaths have been reduced by 71 per cent—from an estimated 548,000 in 2000 to 158,000 in 2011. No single other health interventio...

File Type:

[PDF - 9.18 MB]
Why measles matter : Division of Immunization Services webinar

Personal Author:

Wallace, Gregory S.

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Epidemiology Branch.

Published Date:

May 22, 2014

Series:

Current issues in immunization NetConference (CIINC)

File Type:

[PDF - 1.13 MB]
Rubella and Congenital Rubella Syndrome Control and Elimination — Global Progress, 2000–2012

Personal Author:

Dabbagh, Alya J.; Dumolard, Laure; Gacic-Dobo, Marta; Grant, Gavin B.; Reef, Susan E.;

Published Date:

Dec 06 2013

Source:

MMWR Morb Mortal Wkly Rep. 2013; 62(48):983-986.

Description:

Rubella virus usually causes a mild fever and rash in children and adults. However, infection during pregnancy, especially during the first trimester, can result in miscarriage, stillbirth, or infants with congenital malformations, known as congenita...

File Type:

[PDF - 374.91 KB]
Global Control and Regional Elimination of Measles, 2000–2011

Personal Author:

Perry, Robert T.; Gacic-Dobo, Marta; Dabbagh, Alya; Strebel, Peter M.; Okwo-Bele, Jean-Marie; Goodson, James L.;

Corporate Authors:

World Health Organization

Published Date:

Jan 18 2013

Source:

MMWR Morb Mortal Wkly Rep. 2013; 62(2):27-31.

Description:

Widespread use of measles vaccine since 1980 has led to a substantial decline in global measles morbidity and mortality; measles elimination has been achieved and sustained in the World Health Organization (WHO) Region of the Americas (AMR) since 200...

File Type:

[PDF - 348.61 KB]